3 Surgeon participated in a review of Humacyte's ATEV product and called it revolutionary for their field as a best in class product that is up for FDA approval, this is a great testament to their product.
Surgeons review Humacytes ATEV product that is up for FDA approval and calls it revolutionary to their field Footage from Humacyte's Virtual KOL Event to Discuss Case Studies on the Use of Acellular Tissue Engineered Vessel (ATEV™) in Vascular Trauma Treatment on September 30, 2024
Disclaimer: I am just an ordinary everyday investor and this is all just my own personal opinion and should not be relied upon for any investing decisions. Please do your own research or seek an authorised financial advisor. Video may contain inaccuracies and some of the information mentioned may have changed or may not be relevant at the time of watching.
